In one paragraphArticle in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Andrea Millán-Trejo *Developmental Neurobiology Unit, Instituto de Biomedicina de Valencia Instituto de Biomedicina de Valencia. Consejo Superior de Investigaciones Científicas, Valencia 46010, Spain.ORCID 0000-0003-0003-0173 Carlos Mora-Martínez *Developmental Neurobiology Unit, Instituto de Biomedicina de Valencia Instituto de Biomedicina de Valencia. Consejo Superior de Investigaciones Científicas, Valencia 46010, Spain.ORCID 0000-0002-0542-2654 Adrián Tarazona-SánchezDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia Instituto de Biomedicina de Valencia. Consejo Superior de Investigaciones Científicas, Valencia 46010, Spain.ORCID 0000-0002-7654-9986 Carla Lloret-FernándezDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia Instituto de Biomedicina de Valencia. Consejo Superior de Investigaciones Científicas, Valencia 46010, Spain.ORCID 0000-0002-5370-9318 Rafael AlisDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia Instituto de Biomedicina de Valencia. Consejo Superior de Investigaciones Científicas, Valencia 46010, Spain.
Antonio Jordán-PlaDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia Instituto de Biomedicina de Valencia. Consejo Superior de Investigaciones Científicas, Valencia 46010, Spain.
Arantza BarriosDepartment of Cell and Developmental Biology, University College London, London WC1E 7JE, United Kingdom.
Nuria FlamesDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia Instituto de Biomedicina de Valencia. Consejo Superior de Investigaciones Científicas, Valencia 46010, Spain.ORCID 0000-0003-0961-0609 Funding
EC | Horizon Europe | Excellent Science | HORIZON EUROPE European Research Council (ERC) ERC-Co 101002203- NEUROCODEMinisterio ciencia, innovacion y universidades PID2020-115635RB-I00
6 · The paper itselfAbstract
How nervous systems balance the generation of robust neuron types with gene expression plasticity mechanisms and how these processes impact cell-type evolution are unknown. Here, we use
Indexed as
Adaptation, PhysiologicalBiological EvolutionCaenorhabditis elegansEnhancer Elements, GeneticEpigenesis, GeneticNeuronal PlasticityAnimalsCaenorhabditis elegans ProteinsHistonesMotor NeuronsSerotoninCaenorhabditis elegans ProteinsHistonesSerotoninCaenorhabditisdevelopmental robustnessevolution of neuron typesgene expression plasticitygene regulatory networks
Identifiers
PMID41980100
PMCPMC13099564
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390